PDGFRA as a potential target in H3 K27M mutant gliomas - Hallo friendsTOP POLENNEWS, In the article you read this time with the title PDGFRA as a potential target in H3 K27M mutant gliomas, We have prepared this article for you to read and retrieve information therein. Hopefully the contents of postings Article cultur, Article economic, Article health, Article news, Article politique, Article sport, We write this you can understand. Alright, good read.

Title : PDGFRA as a potential target in H3 K27M mutant gliomas
link : PDGFRA as a potential target in H3 K27M mutant gliomas

PDGFRA as a potential target in H3 K27M mutant gliomas

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

https://www.ncbi.nlm.nih.gov/pubmed/29674595

"We found that H3K27M-glioma primarily contain cells that resemble oligodendrocyte precursor cells (OPC-like), whereas more differentiated malignant cells are a minority. OPC-like cells exhibit greater proliferation and tumor-propagating potential than their more differentiated counterparts and are at least in part sustained by PDGFRA signaling."

PDGFRA is a receptor tyrosine kinase (like EGFR).  No PDGFRA inhibitors have been specifically approved for brain tumors, but inhibitors have been approved for other types of cancers.  Approved PDGFRA inhibiting drugs include imatinib, nilotinib, sorafenib, and dasatinib.

Thus Article PDGFRA as a potential target in H3 K27M mutant gliomas

That's an article PDGFRA as a potential target in H3 K27M mutant gliomas This time, hopefully can give benefits to all of you. well, see you in posting other articles.

You are now reading the article PDGFRA as a potential target in H3 K27M mutant gliomas with the link address https://polennews.blogspot.com/2018/04/pdgfra-as-potential-target-in-h3-k27m.html

Tweet

Subscribe to receive free email updates: